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Human peripheral blood T lymphocytes are transformed in vitro to continuous proliferation by Herpesvirus saimiri
subgroup C strains. It has been previously shown that H. saimiri-transformed human T cell lines are a permissive system for
HIV-1 and 2 replication and are highly susceptible to infection by HIV-1 and 2. Two open reading frames of H. saimiri, StpC
and Tip, are required for T cell transformation and are unique to this herpesvirus. The successful transduction of human T
cells with retroviral vectors expressing H. saimiri proteins StpC and Tip has allowed us to extend the previously mentioned
observations and investigate the role of StpC and Tip in replication of HIV-1 T-tropic strains (IIIB, MN, and RF) in human T
cell lines. StpC expression in Molt4 dramatically enhanced HIV-1 replication as measured by Tat protein expression, syncytia
formation, and accumulation of reverse transcriptase activity. In contrast, Tip expression in Molt4 cells inhibited HIV-1
replication and cytopathic effects relative to Molt4 cells transduced with the empty vector alone. The StpC-induced
phenotype dominated in Molt4 cells transduced to express both StpC and Tip, suggesting that StpC is responsible for
facilitating HIV-1 replication in H. saimiri-transformed T cells. Colony-forming ability of Tip-expressing Molt4 cells following
HIV-1 infection was greatly enhanced over Molt4 cells expressing either StpC or no H. saimiri proteins at all. HIV-1 proviral
DNA could be detected by PCR in surviving Molt4 cells expressing StpC or Tip, indicating that a persistent infection was
established. A better understanding of the effects of Tip and StpC proteins on the biology of human hemopoietic stem cells
may lead to novel therapeutic interventions for the treatment of AIDS. © 1999 Academic Press
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Herpesvirus saimiri is a gamma-herpesvirus, the nat-
ral host of which is squirrel monkeys. H. saimiri does
ot cause disease in its natural host but does induce T
ell lymphomas and leukemias in other New World pri-
ates. In addition, H. saimiri induces transformation of
uman ab and gd T cells in vitro (Biesinger et al., 1992;
asukawa et al., 1995). The transforming ability of H.
aimiri has been localized to the terminal region of the
enome (Desrosiers et al., 1985, 1986). This region in the
enome of H. saimiri group C strains encodes se-
uences for two open reading frames, the products of
hich are Tip (tyrosine kinase interacting protein) and
tpC (saimiri transforming protein subgroup C)
Biesinger et al., 1990; Jung et al., 1991) (Fig. 1). H.
aimiri-transformed CD41 cell lines are highly suscepti-
le to infection with human immunodeficiency virus
1 To whom correspondence and reprint requests should be ad-
ressed at Department of Microbiology and Immunology, Temple Uni-
ersity School of Medicine, 3400 North Broad Street, Philadelphia, PA
9140. Fax: (215) 707-7788. E-mail: eehender@astro.temple.edu.
2 These authors contributed equally to the work presented here.
3 Present address: Kimmel Cancer Center, Jefferson Medical Col-
ege, Thomas Jefferson University, 624 Bluemle Life Sciences Building,
33 S. 10th Street, Philadelphia, PA 19107.
4 Present address: Virology, R & D, Intervet America, Inc., 405 State
itreet, P.O. Box 318, Millsboro, DE 19966.
125ypes 1 and 2 (Nick et al., 1993; Vella et al., 1997; Saha et
l., 1997a). The prototype viruses HIV-1IIIB and HIV-2ROD
eplicated rapidly in these cells and caused their death
ithin 14 days. H. saimiri-transformed CD41 T cells have
lso been found to support enhanced replication of M-
ropic strains of HIV (Vella et al., 1999). H. saimiri-trans-
ormed T cells infected with HIV have been used as
argets for HIV-specific CD81 cytotoxic lymphocytes to
tudy anti-HIV cytotoxic responses (Bauer et al., 1998).
urthermore, H. saimiri transformation has successfully
een used as a tool for immortalizing CD41 and CD81 T
ells from AIDS patients (Saha et al., 1996, 1997b), which
ave been utilized to study the effects of cytokines on
IDS progression (Saha et al., 1998). Considering the
oregoing and the growing interest in the ability of ec-
opic gene expression to influence virus expression and
athogenicity (Coffey et al., 1998; Marshall et al., 1999;
un and Clark, 1999), we wanted to investigate the role of
he two unique H. saimiri-encoded proteins, StpC and
ip, in HIV-1 replication in the T cell line Molt4. Molt4
ells were previously transduced to express StpC, Tip, or
tpC and Tip (Merlo et al., 1998). The effects of expres-
ion of StpC and/or Tip on HIV-1 replication have been
etermined, extending the work of others on the effects
f H. saimiri virus on HIV-1 expression. We discovered a
ichotomous effect of StpC and Tip on HIV-1 replication,n that StpC enhanced replication, whereas Tip re-
0042-6822/99 $30.00
Copyright © 1999 by Academic Press
All rights of reproduction in any form reserved.
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126 HENDERSON ET AL.ressed it. Importantly, in double transductants express-
ng StpC and Tip, StpC was dominant with regard to its
ffect on HIV replication, suggesting that StpC expres-
ion is responsible for the high susceptibility of H.
aimiri-transformed CD41 cell lines to HIV-1 infection.
he mechanism(s) whereby StpC and Tip might modu-
ate HIV-1 replication is discussed as is the potential
sefulness of these unique H. saimiri-encoded proteins
n engineering T cells with modified ability to support
IV-1 replication.
RESULTS
HIV-1 expression in T cell line Molt4 retrovirally trans-
uced to express StpC, Tip, or both Tip and StpC. The
nfected-centers assay was used to determine the num-
er of syncytia-producing cells following infection with
he HIV-1 T-tropic strain IIIB. HIV-1 replicated 4-fold more
fficiently in both single and double transductants of
olt4 cells expressing StpC than in Molt4 cells trans-
uced with pac, neo, or both pac and neo (Table 1). In
ontrast, Molt4 cells transduced to express Tip produced
0-fold fewer syncytia. Accumulation of reverse tran-
criptase (RT) activity in IIIB-infected transduced Molt4
FIG. 1. H. saimiri strain C488: genome anells corroborated the finding with syncytia formation. mip expression in Molt4 inhibited the accumulation of RT
ctivity, whereas StpC expression enhanced the accu-
ulation of RT activity nearly 3-fold (Table 2). In addition,
8 h after infection, HIV-1-encoded Tat protein was ap-
formation-related open reading frames.
TABLE 1
Syncytia Formation in Molt4 Cells Transduced
to Express Tip or StpC
Cell lines
Syncytia formation per 103 cells
at 72 h following infectiona
(mean 6 SD)
Percentage
of control
ingle transductants
M4 pac 14.5 6 1.5 100
M4 StpC pac 62 6 4.5 414
M4 Tip neo 0.25 6 0.5 1.7
M4 neo 15.5 6 1.5 107
ouble transductants
Molt4 cells
(nontransduced) 17.5 6 2.0 100
M4 neo pac 18 6 2.5 103
M4 Tip neo pac 0.5 6 0.5 2.9
M4 neo StpC pac 62 6 3.0 354
a Infection with cell-free IIIB at a multiplicity of infection of approxi-
ately 0.1 as measured by limiting dilution on SupT1 cells.
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127HIV REPLICATION IN Tip- AND StpC-EXPRESSING T CELLSroximately 4-fold more abundant in StpC-expressing
olt4 cells than in control Molt4 cells expressing no H.
aimiri proteins (Fig. 2).
Our first experiments suggested that StpC or Tip could
nfluence HIV-1 expression. To confirm these results a
ime course analysis of syncytia formation by the T-tropic
trains IIIB, MN, and RF was carried out using Molt4
ells expressing StpC, Tip, StpC and Tip, or no H. saimiri
roteins at all. The HIV-1 T-tropic strains IIIB, RF, and MN
eplicated more efficiently in double transductants of
olt4 cells expressing StpC, while in contrast, IIIB, RF,
nd MN all replicated poorly in Molt4 cells transduced to
xpress Tip (Fig. 3). In double transductants expressing
oth StpC and Tip, IIIB, RF, and MN replication was
nhanced to the level seen in cells expressing only StpC.
Fate of Molt4 cells transduced with StpC, Tip, or StpC
nd Tip following infection with HIV-1 IIIB, RF, or MN.
hen visualized microscopically, there was a dramatic
eduction in cytopathic effect (CPE) induced by HIV-1 in
ultures of Molt4 transduced with Tip when compared to
olt4 cells expressing either StpC or no H. saimiri pro-
TABLE 2
Effects of StpC and Tip Expression in Molt4 Cells on HIV-1 IIIB
Replication as Measured by Accumulation of RT Activitya
Cell lines
cpm
(mean 6 SD) Percentage of control
olt4 1548 6 132 100
olt4 Neo 1424 6 31 92
olt4 pac 1632 6 23 105
olt4 Tip Neo 617 6 76 40
olt4 StpC pac 4202 6 215 271
a Experiment repeated three times.
FIG. 2. Expression of Tat in HIV-infected Molt4 cells expressing Tip
r the corresponding empty vectors were infected with HIV for the time
-cysteine and lysed. Cell lysates were subjected to immunoprecipita
xpression, gels were scanned using an Astra 1220S Scanner (UMAX, Fremoeins at all. To determine whether there was a difference
n cell survival of StpC- and Tip-transduced Molt4 cells
ollowing HIV-1 infection, the colony-forming ability of
ells from the infected cultures was determined by lim-
ting dilutions 72 h after infection (Table 3). Fewer than 1
n 103 Molt4 cells transduced with empty vectors alone
pac or neo) survived HIV-1 infection to develop into
lones. Fewer than 1 in 105 cells formed colonies from
olt4 cells expressing StpC following infection with
IV-1 IIIB. In contrast, greater than 1 in 10 of the Molt4
ells expressing Tip survived to form colonies after in-
ection with HIV-1. Double transductants expressing both
tpC and Tip had the level of colony-forming ability after
IV-1 infection reduced to the level seen in Molt4 cells
xpressing only StpC.
Virological status of clones surviving HIV-1 infection.
lthough there were survivors from all Molt4 transduc-
ants able to form colonies after HIV-1 IIIB infection, we
id not know whether or not the survivors had been
nfected with HIV-1. Two methods were used to deter-
ine the HIV-1 status of cells giving rise to the surviving
lones. First, PCR analysis of the DNA from the clones
emonstrated HIV-1 proviral sequences in the surviving
lones of all the transductants examined (Fig. 4). Second,
onsistent with the presence of proviral DNA, a certain
evel of RT accumulation was observed in all the surviv-
ng clones (data not shown). A proviral DNA signal and
resence of RT support the notion that a persistent in-
ection could be maintained by at least some T-tropic
trains of HIV-1 in Molt4 cells expressing Tip, StpC, or
ip and StpC. To confirm this, we determined whether
nfectious virus could be recovered from these expanded
lones. Nearly all clones examined from IIIB- or MN-
nfected Molt4 cells transduced to express Tip, Tip and
StpC. Molt4 cells transduced with pMSCVpac/StpC or pMSCVneo/Tip
ted at the top of the figure. Cells were labeled with [35S]L-methionine/
ith rabbit polyclonal anti-Tat or normal rabbit serum. To quantify Tatand/or
indica
tion w
nt, CA), and the scans were analyzed using NIH Image software.
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128 HENDERSON ET AL.tpC, or no H. saimiri proteins at all induced syncytia
hen cocultured with indicator cells (Table 4). In con-
rast, fewer clones expanded from Molt4 transduced to
xpress only StpC and a lower number of these survivors
nduced syncytia whether initially infected with HIV-1
train IIIB, MN, or RF. HIV-1RF appeared to be particularly
ytolytic in Molt4 cells expressing only StpC or Tip and
tpC.
DISCUSSION
We have previously reported the successful transduc-
ion of human T cell lines with retroviral-based vectors
iving rise to transductants expressing H. saimiri-en-
oded StpC and Tip proteins (Merlo et al., 1998). Based
n the previous observation that H. saimiri-transformed T
ell lines are permissive for HIV-1 replication, we deter-
ined the ability of StpC and Tip to affect acute infection
ith HIV-1 IIIB. Molt4 cells transduced to express StpC
upport HIV-1 replication to a higher level than do control
olt4 cells as measured by Tat expression, syncytia
ormation, and accumulation of RT activity. In contrast,
olt4 cells transduced to express Tip supported HIV
eplication to a lower level than did control Molt4 cells
sing the same criteria. Molt4 cells transduced to ex-
ress both Tip and StpC supported HIV replication at a
evel similar to that of Molt4 cells expressing StpC alone.
hese results suggest that the enhancing effects of StpC
n HIV-1 replication are dominant over the inhibitory
ffects of Tip expression on HIV-1 expression in the
bsence of a background of other H. saimiri proteins.
ata presented in this study converge upon the conclu-
ion that StpC is responsible for establishing the permis-
ive state for HIV-1 lytic replication in T cells naturally
ransformed by H. saimiri.
HIV-1 was able to form a persistent infection in either
ip- or StpC- or both Tip- and StpC-expressing Molt4
ells. However, the resistance of various Molt4 lines to
FIG. 3. Time course for syncytia induction by HIV-1 T-tropic strains I
r StpC and Tip were infected with IIIB, MN, or RF at a multiplicity of infe
ormation as described (Zhang et al., 1997). Syncytia were measured aytopathic effects of HIV was clearly different, as evidentrom their colony-forming efficiency after HIV infection.
olt4 cells expressing StpC alone were less resistant to
he cytopathic effects of HIV than were control cells,
hereas Molt4 cells expressing Tip demonstrated a sig-
ificant increase in resistance. The StpC-induced phe-
otype dominated in Molt4 cells transduced to express
oth StpC and Tip. Therefore, the effects of Tip and StpC
n the resistance of Molt4 cells to the cytopathic effects
f HIV-1 were consistent with their effects on HIV repli-
ation in Molt4 cells.
The reason(s) for the dichotomous effects of Tip and
tpC on HIV-1 replication in Molt4 cells and on the
esistance of these cells to the cytopathic effects of HIV-1
ay be based on the differential effects of these proteins
n T cell activation machinery. Considering what is
nown about the effects of Tip and StpC on T cells, it is
TABLE 3
Colony-Forming Ability of Molt4 Cells Transduced with StpC, Tip,
or Both StpC and Tip Following Infection with HIV-1
Cell lines
Percentage colony-forming ability as
measured by limiting dilutions
Control
Following infection with
IIIB MN RF
ingle transductants
M4 pac .90 0.01–0.1 NDa ND
M4 StpC pac .90 #0.001 ND ND
M4 Tip neo .90 $10.0 ND ND
M4 neo .90 0.01–0.1 ND ND
ouble transductants
M4 neo pac .90 0.01–0.1 0.1–0.10 0.1–0.10
M4 Tip neo pac .90 $10.0 $10.0 $10.0
M4 neo StpC pac .90 #0.005 #0.005 #0.0001
M4 Tip neo StpC pac 1 .90 #0.005 #0.002 #0.001
M4 Tip neo StpC pac 2 .90 #0.005 #0.002 #0.001
, and RF. Molt4 cells or Molt4 cells transduced to express StpC, Tip,
f 0.10 for 2 h at 37°C, washed, and serially diluted to measure syncytia
8, and 72 h postinfection.IIB, MN
ction oa ND, not determined.
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129HIV REPLICATION IN Tip- AND StpC-EXPRESSING T CELLSikely that these proteins affect T cell/HIV interactions by
nterfering with T cell signaling pathways. It has previ-
usly been shown that StpC binds to and activates Ras,
small GTPase playing a crucial role in cellular signal-
ng. For instance, the activation of the AP-1 transcription
omplex, which is critical for the activation of HIV proviral
xpression (Canonne-Hergaux et al., 1995; Roebuck et
l., 1996; el Kharroubi and Martin, 1996; Di Somma et al.,
996), is Ras-dependent (Hall, 1994; Whitmarsh and
avid, 1996). Therefore, an increase in HIV replication
aused by the expression of StpC in Molt4 cells may be
elated to the upregulation of Ras by StpC. It is also
ossible that StpC upregulates HIV-1 replication by bind-
ng to cellular tumor necrosis factor receptor-associated
actor (TRAF), inducing NF-kB activation (Lee et al., 1999).
The effects of Tip upon the replication of HIV in Molt4
ells and the survival of HIV-infected cells might be
elated to the ability of Tip to interact with the T cell-
pecific protein tyrosine kinase Lck. This tyrosine kinase
s critically important for T cell activation through TcR/
D3 and other receptors (Tsygankov and Bolen, 1993;
eiss and Littman, 1994; Mustelin, 1994). HIV infection
ppears to significantly affect Lck activity, expression,
nd responsiveness to extracellular stimuli, although the
haracter of these effects remains controversial, since
oth activation and inhibition of Lck have been demon-
trated (Hubert et al., 1995; Di Somma et al., 1996; Phipps
t al., 1996; Tian et al., 1996; Morio et al., 1997). However,
hese findings convincingly indicate that Lck is involved
n the interactions between HIV and the host cell. We and
ther researchers have previously demonstrated that Tip
pecifically binds to the T cell-expressed protein tyrosine
inase Lck and upregulates its enzymatic activity
Biesinger et al., 1995; Wiese et al., 1996; Lund et al.,
997). Tip has also been shown to be a negative regu-
ator of Lck in Jurkat cells expressing Tip as a result of
table transfection (Jung et al., 1995). This finding sug-
ests that the biological effects of Tip may differ in
ifferent cellular systems. Although Tip-positive Molt4
FIG. 4. Analysis of transduced cell lines transfected with neo, pac,
tpC, or tip and infected with HIV-1 IIIB by DNA-PCR. Products from
CR, performed with HIV-1-specific primer pairs, were resolved by 1.4%
garose gel and stained with ethidium bromide. The molecular size
arkers are indicated on the left. The products of HIV-1 are ENV, 364
p; LTR, 342 bp; POL, 544 bp; and GAG, 445 bp.ells, utilized in our study, demonstrate no change in Lckctivity or expression, they show a significant increase in
he overall protein tyrosine phosphorylation (Merlo and
sygankov, submitted for publication). This finding is
onsistent with the notion that Tip activates Lck in T
ells. However, further studies, which are currently in
rogress in our laboratory, are required to elucidate the
echanisms mediating the effects of Tip on HIV infec-
ion. One of the most important issues to be addressed
s whether the observed effects of Tip are mediated by T
ell signaling or by direct interactions of Tip with the HIV
rotein(s).
To summarize, our results indicate that the StpC pro-
ein unique to H. saimiri renders Molt4 cells highly sus-
eptible to HIV-1 replication, whereas the Tip protein
ncoded by this virus inhibits, to some extent, the repli-
ation and cytopathic effects of HIV-1. The influence of
ip and StpC is likely to be mediated by their interactions
ith T cell signal transduction pathways important for
IV-1 replication. These results allow us to propose that
ild-type Tip and/or dominant-inhibitory mutants of StpC
ay possibly be used to engineer stem cells resistant to
IV-1 infection. To pursue this goal, it remains to be
stablished whether or not Tip and dominant-negative
tpC proteins are pathogenic in humans and whether
uman hemopoietic stem cells expressing these pro-
eins may eventually become susceptible to host im-
une responses. A number of human gene therapy clin-
cal trials have been carried out worldwide over the past
ecade, and many of these studies have adopted retro-
iral vectors to deliver functional genes into humans for
he gene-based treatment of inherited genetic disorders.
s a rule, immunogenicity was not a problem in studies
nvolving retroviral-mediated gene transfer of therapeutic
TABLE 4
Syncytia Induction by Individual Clones Established from HIV-1
IIIB, MN, or RF)-Infected Molt4 Transductants Expressing Tip, StpC,
ip and StpC, or no H. saimiri Proteins at All
Double transductant
HIV-1
strain
Clones inducing syncytia/
clones examined Ratio
4 neo pac IIIB 3/4 0.75
MN 4/4 1.0
RF 4/4 1.0
4 Tip neo pac IIIB 4/4 1.0
MN 4/4 1.0
RF 4/4 1.0
4 neo StpC pac IIIB 2/3 0.66
MN 3/3 1.0
RF —a —
4 Tip neo StpC pac 1 IIIB 4/4 1.0
MN 4/4 1.0
RF 2/2 1.0
4 Tip neo StpC pac 2 IIIB 4/4 1.0
MN 4/4 1.0
RF 2/4 0.5a Surviving clones failed to successfully expand.
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130 HENDERSON ET AL.enes and selection markers into T cells and bone mar-
ow-derived cells (Deisseroth et al., 1994; Heslop et al.,
996; Kohn et al., 1995; Merrouche et al., 1995; Rooney et
l., 1995; Rosenberg et al., 1990; van Beusechem et al.,
992). However, T-cell-mediated rejection of gene-modi-
ied autologous T cells was demonstrated in at least one
tudy (Riddell et al., 1996). The other safety issue that
ust be considered is the potential tumorigenicity of Tip
nd dominant-negative StpC in humans. It is unlikely to
e a problem for Tip, which has never been shown to
ransform any cell type. In particular, expression of Tip in
he absence of StpC is insufficient for T cell transforma-
ion (Duboise et al., 1998; Medveczky et al., 1993). Al-
hough wild-type StpC is oncogenic in fibroblasts and
pithelial cells (Jung et al., 1991; Murphy et al., 1994), its
xpression in the absence of Tip is insufficient for T cell
ransformation (Duboise et al., 1998; Medveczky et al.,
993). Furthermore, dominant-negative forms of StpC are
nlikely to be oncogenic, like nonfunctional StpC mu-
ants shown to be unable to transform fibroblasts (Jung
nd Desrosier, 1994, 1995; Lee et al., 1999). However, all
hese safety issues need to be addressed by generating
rimary human hemopoietic stem cells expressing Tip
nd dominant-inhibitory StpC proteins. We are currently
ttempting to produce these primary cell culture sys-
ems. In addition, experiments to unravel the mecha-
isms whereby StpC and Tip modulate HIV-1 replication
nd to determine the extent of their protective effect
gainst the cytopathic action of HIV-1 are in progress.
MATERIALS AND METHODS
Cells. Human Molt4 lymphoblastoid T cells were ob-
ained from ATCC. They were transduced to express Tip
nd/or StpC as described previously (Merlo et al., 1998).
riefly, MSCV-based retroviral vectors (Hawley et al.,
994) encoding Tip or StpC and the corresponding con-
rol vectors were used to produce retroviral stocks in a
hree-plasmid transient cotransfection system. The ret-
oviral vector was harvested and utilized to transduce
olt4 T cells as previously described (Merlo et al., 1998).
he target cells transduced with pac or stpC/pac vectors
ere selected using puromycin (Sigma, St. Louis, MO),
hereas those transduced with neo or neo/tip vectors
ere selected with G418 (Mediatech, Herndon, VA). The
ells transduced with both pac- and neo-encoding vec-
ors were selected using puromycin and G418. T cells
ere cloned by limiting dilution following the beginning
f selection. In the experiments with cells transduced
ith a single retroviral vector (single transductants),
OLT4 cells expressing pac only, neo only, StpC plus
ac, and Tip plus neo were each represented by one
ndividual clone. Tip1 and StpC1 clones were StpC C2
nd Tip1 as described in Merlo et al. (1998). In the
xperiments with cells consecutively transduced withwo retroviral vectors carrying different selection mark- ars (double transductants), three cell types (neo/pac,
eo/StpC-pac, Tip-neo/pac) were represented by a sin-
le clone each. Tip1StpC1 cells (Tip-neo/StpC-pac) were
epresented by two individual clones, which demon-
trate no difference in the ability to support HIV prolifer-
tion (see Fig. 3). The double transductants and the
ingle transductants used in the current study were de-
ived in independent experiments (Merlo et al., 1998).
AR-61/52 is a nontransformed human CD41 T cell clone,
indly provided by B. Bro¨ker (Bernhardt Nocht Institute,
amburg, Germany). P-1088 is a human CD41 T cell line
ransformed by H. saimiri in vitro and kindly provided by
. Biesinger (University of Erlangen–Nu¨rnberg, Erlangen,
ermany). Molt4 cells were grown in RPMI 1640 medium
upplemented with 10% fetal bovine serum, L-glutamine,
ntibiotics, and HEPES (Gibco BRL, Grand Island, NY).
-1088 cells were grown in the same medium supple-
ented with 100 IU/ml recombinant human IL-2. TAR-
1/52 cells were grown in the same medium as P-1088
nd restimulated with PHA and irradiated peripheral
lood mononuclear cells every 3 weeks. Peripheral
lood mononuclear cells were isolated using centrifuga-
ion in Ficoll-Paque (Pharmacia Biotech, Piscataway, NJ).
HIV-1 source. HIV-1 strains IIIB RF and MN were ob-
ained from the AIDS Research and Reference Reagent
rogram (Division of AIDS, NIAID, Rockville, MD), prop-
gated, and partially purified as described (Zhang et al.,
997).
Syncytia formation. HIV-1 replication was detected by
easuring syncytia induction. Briefly, the T cell clones
ere incubated with the virus at a multiplicity of infection
f 0.1 at 37°C for 2 h. The cells were washed and seeded
nto individual wells of a 96-well microtiter plate at a
ensity of 1 3 104 cells per well and incubated for 3 days.
he cells were then serially diluted and syncytia were
etected by the addition of 2 3 105 Sup T1 cells to each
ell. The wells were examined daily with an inverted
icroscope for the presence of syncytia, and the number
f syncytia was measured at 24, 48, and 72 h.
RT activity. HIV-1 replication was also detected by
easuring accumulation of RT activity. Briefly, the T cell
lones were incubated with the virus at a multiplicity of
nfection of 0.1 at 37°C for 2 h. The cells were washed,
eeded into individual wells of a 96-well microtiter plate,
nd incubated. At various times the culture supernatants
ere harvested for the RT assay. Twenty-five microliters
f the supernatant was added to 50 ml of the RT cocktail
50 mM Tris, pH 8.0, 20 mM DTT, 10 mM MgCl2, 60 mM
aCl, 0.05% NP-40, 5 mg/ml oligodeoxythymidilic acid, 10
g/ml polyriboadenylic acid, 10 mM deoxythymidine
riphosphate, and 0.5 mCi [32P]TTP) and reacted for 2 h.
he reactions were filtered through DEAE paper under
acuum, and the paper was washed twice with 23 SSC
or 10 min each and then with alcohol. The samples
ound on DEAE papers were counted for radioactivity
nd data are expressed as counts per minute (cpm).
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131HIV REPLICATION IN Tip- AND StpC-EXPRESSING T CELLSDetection of HIV-1 DNA in persistently infected T cell
lones. Genomic DNA was extracted from 2 3 107 cells
nfected with HIV-1 IIIB with a DNA purification kit (Blood
nd Cell DNA Maxi Kit, Qiagen, Chatsworth, CA), follow-
ng the manufacturer’s instructions. PCR analysis of
IV-1 DNA was carried out with 10 mg of genomic DNA.
he oligonucleotide primers are listed in Table 5. Ampli-
ication products were analyzed by electrophoresis
hrough a 1.5% agarose gel and stained with ethidium
romide. This was performed by PCR using the sense
nd antisense primer pairs listed in Table 5.
Antibodies. Antisera specific to Lck, Tip, and StpC
ere raised in New Zealand white rabbits in accordance
ith institutional guidelines using fragments of Lck
amino acids 8–64), Tip (amino acids 1–116), and StpC
amino acids 1–77) fused to the C-terminus of glutathione
-transferase (GST). GST-fusion proteins were produced
n Escherichia coli using pGEX-2T expression vector
Pharmacia Biotech) and purified on glutathione–Sepha-
ose columns as previously described (Tsygankov et al.,
994). Rabbit polyclonal antibodies to Tat were obtained
hrough B. Cullen of the AIDS Research and Reference
eagent Program.
Immunoprecipitation, immune complex kinase assays,
nd immunoblotting. Methods of immunoprecipitation,
mmunoblotting, and immune complex kinase assays
ere described in detail in our previous publications
Bro¨ker et al., 1994; Biesinger et al., 1995; Wiese et al.,
996; Merlo et al., 1998). Briefly, T cells were lysed in
ris/NaCl/EDTA buffer containing 1% NP-40 and inhibi-
ors of proteases and protein phosphatases. Protein con-
entrations were determined in precleared lysates using
oomassie reagent (Pierce, Rockford, IL), and aliquots of
hese lysates containing equal amounts of total cellular
rotein were incubated with appropriate antisera. Incu-
ation with antisera was followed by incubation with
uspension of Staphylococcus aureus-derived PAN-
ORBIN particles (Calbiochem, La Jolla, CA). The result-
ng immunoprecipitates were washed five times in TNE
uffer and used for either immunoblotting or immune
T
Oligonucleotide Primer Pairs Used in PCR A
Genome
region
Primer pair
designation
Genome
coordinates
Pol
PS 59 4283–4303
PA 39 4807–4827
Env
ES 59 6969–6989
EA 39 7313–7333
LTR
LS 59 521–540
LA 39 843–862omplex kinase assays.For immune complex kinase assays, immunoprecipi-
ates were additionally washed in kinase buffer (20 mM
OPS, pH 7.0, containing 5 mM MgCl2) and subjected to
inase reaction in 25 ml of kinase buffer containing
g-32P]ATP (NEN, Boston, MA) at a final concentration of
.5 mCi/ml. The reaction was stopped by boiling. Super-
atants of the reaction mixtures were collected and then
iluted 1:10 with Tris/NaCl/EDTA/1% Triton X-100 buffer
ontaining protease and phosphatase inhibitors. Pro-
eins of interest were reprecipitated with the correspond-
ng antibodies and subjected to SDS–PAGE separation.
hosphoprotein bands were visualized by autoradiogra-
hy.
For immunoblotting, whole-cell lysates or immunopre-
ipitates were treated with SDS–PAGE sample buffer.
roteins of these lysates or immunoprecipitates were
eparated by SDS–PAGE and transferred to nitrocellu-
ose (Bio-Rad Laboratories, Richmond, CA). Nitrocellu-
ose was blocked in Tris-buffered saline containing 1%
SA and 0.1% Tween 20, and incubated with an appro-
riate antibody diluted in blocking buffer. Protein bands
ere visualized by autoradiography.
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